Bessemer Group Inc Nuvation Bio Inc. Transaction History
Bessemer Group Inc
- $55.8 Billion
- Q1 2025
A detailed history of Bessemer Group Inc transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 122 shares of NUVB stock, worth $285. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122Holding current value
$285% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
167Shares Held
156MCall Options Held
4.6KPut Options Held
154K-
Decheng Capital LLC Menlo Park, CA26MShares$60.7 Million12.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$36 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$30.6 Million47.43% of portfolio
-
Laurion Capital Management LP New York, NY9.87MShares$23.1 Million0.45% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $508M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...